Archives

Hep-C Outcomes 2022 216 115 Shields Health Solutions

Hep-C Outcomes 2022

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.

HIV Outcomes 2022

HIV Outcomes 2022 216 115 Shields Health Solutions

Human immunodeficiency virus (HIV) is a virus spread through contact with certain fluids of an infected person, attacking the immune system and affecting the body's ability to fight infections and certain cancers. HIV is incurable and can progress to the most advanced disease stage if left untreated, known as Acquired Immunodeficiency Syndrome (AIDS).

https://shieldshealthsolutions.com/content/uploads/2023/09/Shields_HIV_Sheet_2023-1.pdf#new_tab
The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes 204 115 Shields Health Solutions

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes

STOUGHTON, Mass.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, recently published its latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA),…

Shields Health Solutions and Erlanger Partner to Introduce Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and Erlanger Partner to Introduce Specialty Pharmacy Services

STOUGHTON, Mass. & CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, announced today that it has partnered with Tennessee-based Erlanger to establish a new specialty pharmacy…

PAH Care Model Provides a Road Map for Rare Disease Treatment 204 115 Shields Health Solutions

PAH Care Model Provides a Road Map for Rare Disease Treatment

The Shields Health Solutions care model for helping pharmacies and providers treat patients with pulmonary arterial hypertension (PAH) integrates a patient’s entire care team, and can be adopted to successfully…

New Drugs and the Opportunity for Integrated Care in the Healthcare Industry 204 115 Shields Health Solutions

New Drugs and the Opportunity for Integrated Care in the Healthcare Industry

This article was originally published by the Forbes Business Council on August 18, 2023. Scientific discovery’s rapid pace has led to a constant drumbeat of new drugs entering the market,…

Care Team Clinical Pharmacists Help Optimize Treatment for Patients With ALS 1024 683 Shields Health Solutions

Care Team Clinical Pharmacists Help Optimize Treatment for Patients With ALS

As we recognize amyotrophic lateral sclerosis (ALS) Awareness Month in May, the disease remains without a cure. A rare and fatal neurodegenerative disease characterized by a progressive degeneration of motor…

How Specialty Pharmacy Can Address and Impact Social Determinants of Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Address and Impact Social Determinants of Health
Social determinants of health can become barriers to patients receiving adequate health care and are drivers of most health outcomes.
Shields Health Solutions and Elliot Health System Establish New Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and Elliot Health System Establish New Specialty Pharmacy Services

STOUGHTON, Mass. & MANCHESTER, N.H.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, announces that it is partnering with Elliot Health System, the largest provider of…